Danimer Scientific, Inc.

As previously disclosed, the Registrant has undertaken an ongoing comprehensive program of capital conservation and expense reduction, and is also analyzing a variety of transactions to provide additional sources of liquidity. These efforts and discussions have involved significant time by members of the Registrant's management and its Board of Directors. As a result of the increased workload associated with these efforts, including their impact on procedures related to finalizing its quarterly filing, the Registrant is unable to file its Form 10-Q for the quarterly period ended September 30, 2024 within the prescribed time period without unreasonable effort or expense. The Registrant intends to file this Form 10-Q no later than the prescribed due date provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended. The Registrant anticipates that this Form 10-Q will disclose that substantial doubt exists about the Registrant's ability to continue as a going concern for twelve months following the expected issuance date of the Form 10-Q

The Registrant was unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the period ended December 31, 2021 (the “Annual Report”) by the prescribed due date. As previously disclosed in the Registrant’s Earnings Release, dated February 28, 2022, as filed on Form 8-K on the same date, the Registrant disclosed that it had identified certain material weaknesses in its internal control over financial reporting. The Registrant has determined these material weaknesses related to risk assessment, product revenue, stock-based compensation expense, income taxes, and processing and paying vendor invoices for certain contracts. As a result, the Registrant needs additional time to finalize the evaluation of its disclosure controls and procedures and internal control over financial reporting in order to complete its Annual Report. As a result, the Registrant’s independent registered accounting firm, KPMG LLP, has not yet been able to complete its audit and report on the Registrant’s consolidated financial statements and internal control over financial reporting to be included in the Annual Report. Based on the reviews and analyses to date, the Registrant does not expect adjustments to its previously announced financial results. The Registrant is working diligently to finalize its assessment of disclosure controls and procedures and internal control over financial reporting in order to complete its Annual Report. The Registrant expects to file its Annual Report no later than the prescribed due date pursuant to Rule 12b-25 promulgated under the Securities Exchange Act of 1934

The Registrant was unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the “Quarterly Report”) by the prescribed due date for the reasons described below. As previously disclosed, in light of the Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”) (the “Staff Statement”) issued by the staff of the Securities and Exchange Commission (the “SEC”) on April 12, 2021, the audit committee of the Company’s board of directors, together with management, determined that the Company’s consolidated financial statements and related financial information as of and for the fiscal year ended December 31, 2020 contained in the Company’s Annual Report on Form 10-K filed with the SEC on March 30, 2021 (the “Original 10-K”), should be restated. On May 14, 2021, the Company filed restated financial statements as of and for the fiscal year ended December 31, 2020 in Amendment No. 1 to the Original 10-K (the “Restatement”). In sum, as a result of the considerable time and dedication of resources required to complete the Restatement, the Company was unable to file its Quarterly Report by its prescribed due date without unreasonable effort or expense. In accordance with Rule 12b-25 under the Securities Exchange Act of 1934, the Registrant anticipates filing its Form 10-Q no later than five calendar days following the prescribed due date